AstraZeneca Vietnam and Cho Ray Hospital have today signed a memorandum of understanding (MoU) from 2023 to 2025 to deepen medical knowledge of healthcare workers and better serve the needs of patients in Ho Chi Minh City and the broader Southeast Vietnam region.
The three-year agreement will enhance the implementation of clinical trials, medical workforce training series, patient support program and further international integration activities of Cho Ray hospital. The comprehensive collaboration will cover a variety of therapeutic areas such as oncology; respiratory and gastrointestinal diseases; cardiovascular, renal and metabolism; and vaccines and immune therapies.
Nitin Kapoor, Chairman and General Director of AstraZeneca Vietnam and Asia Area Frontier Markets, said: “AstraZeneca is dedicated to transforming outcomes for patients and increasing access to better healthcare for everyone. Furthering our collaboration with Cho Ray hospital, one of the leading hospitals in the country with profound expertise, will expand the positive impact that we jointly make on local communities in Ho Chi Minh city and millions of other patients across the country.”
Cho Ray Hospital is well-known for its extensive expertise as one of the leading general hospitals in Vietnam, and a center of healthcare excellence for the Southeast region which plays a key role in closing the gaps between urban hospitals and rural hospitals through technology transfer. Caring for thousands of outpatients each day as well as delivering top-tier inpatient treatment, the hospital’s management team sets their highest priority as constantly improving their health staff’s capabilities to meet the increasing needs of patients, many of whom travel from far distances.
Specialist II Nguyen Tri Thuc MD., PhD., Cho Ray Hospital Director commented: “Sharing the mission towards putting patients first, we are pleased to partner with AstraZeneca, a leading global biopharmaceutical company, to accelerate our innovation and international integration progress, build up capabilities for our workforce and deliver new program to increase our patients’ access to innovative treatment. Our enhanced capabilities will support colleagues at Southern hospitals to develop their skills, in hopes that patients can receive the treatment they need in their hometowns.”
The MoU is the latest milestone of the partnership between AstraZeneca and Cho Ray hospital. So far, they have collaborated to implement more than 30 clinical trials in different therapeutic areas, many scientific congresses, continued medical trainings, and patients support program.
Press release distributed by EloQ Communications.